Genus PLC (GNS) - Total Liabilities
Based on the latest financial reports, Genus PLC (GNS) has total liabilities worth GBX423.00 Million GBX (≈ $51.47K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Genus PLC to assess how effectively this company generates cash.
Genus PLC - Total Liabilities Trend (1996–2025)
This chart illustrates how Genus PLC's total liabilities have evolved over time, based on quarterly financial data. Check GNS asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Genus PLC Competitors by Total Liabilities
The table below lists competitors of Genus PLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nexen Tire Prf 1
KO:002355
|
Korea | ₩2.95 Trillion |
|
CNFinance Holdings Ltd
NYSE:CNF
|
USA | $8.49 Billion |
|
Epsium Enterprise Limited Ordinary Shares
NASDAQ:EPSM
|
USA | $1.59 Million |
|
Blender Financial Technologies Ltd
TA:BLND
|
Israel | ILA135.04 Million |
|
NexgenRX Inc.
V:NXG
|
Canada | CA$30.91 Million |
|
Austin Gold Corp
NYSE MKT:AUST
|
USA | $128.82K |
|
Medifron DBT Co. Ltd
KQ:065650
|
Korea | ₩86.61 Billion |
|
Ozaurum Resources Ltd
AU:OZM
|
Australia | AU$443.16K |
Liability Composition Analysis (1996–2025)
This chart breaks down Genus PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Genus PLC market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.94 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.89 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Genus PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Genus PLC (1996–2025)
The table below shows the annual total liabilities of Genus PLC from 1996 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | GBX423.00 Million ≈ $51.47K |
-12.78% |
| 2024-06-30 | GBX485.00 Million ≈ $59.01K |
+10.15% |
| 2023-06-30 | GBX440.30 Million ≈ $53.57K |
-1.23% |
| 2022-06-30 | GBX445.80 Million ≈ $54.24K |
+25.79% |
| 2021-06-30 | GBX354.40 Million ≈ $43.12K |
-1.80% |
| 2020-06-30 | GBX360.90 Million ≈ $43.91K |
+14.03% |
| 2019-06-30 | GBX316.50 Million ≈ $38.51K |
-14.48% |
| 2018-06-30 | GBX370.10 Million ≈ $45.03K |
-6.42% |
| 2017-06-30 | GBX395.50 Million ≈ $48.12K |
+6.60% |
| 2016-06-30 | GBX371.00 Million ≈ $45.14K |
+9.38% |
| 2015-06-30 | GBX339.20 Million ≈ $41.27K |
+13.48% |
| 2014-06-30 | GBX298.90 Million ≈ $36.37K |
-3.55% |
| 2013-06-30 | GBX309.90 Million ≈ $37.71K |
-0.86% |
| 2012-06-30 | GBX312.60 Million ≈ $38.03K |
+15.99% |
| 2011-06-30 | GBX269.50 Million ≈ $32.79K |
-7.26% |
| 2010-06-30 | GBX290.60 Million ≈ $35.36K |
-0.92% |
| 2009-06-30 | GBX293.30 Million ≈ $35.69K |
+16.90% |
| 2008-06-30 | GBX250.90 Million ≈ $30.53K |
-11.62% |
| 2007-06-30 | GBX283.90 Million ≈ $34.54K |
-9.09% |
| 2006-06-30 | GBX312.30 Million ≈ $38.00K |
+44.96% |
| 2006-03-31 | GBX215.44 Million ≈ $26.21K |
+304.13% |
| 2005-03-31 | GBX53.31 Million ≈ $6.49K |
+15.13% |
| 2004-03-31 | GBX46.31 Million ≈ $5.63K |
+107.24% |
| 2003-12-31 | GBX22.34 Million ≈ $2.72K |
-58.66% |
| 2003-03-31 | GBX54.05 Million ≈ $6.58K |
+95.03% |
| 2002-12-31 | GBX27.71 Million ≈ $3.37K |
-40.26% |
| 2002-03-31 | GBX46.39 Million ≈ $5.64K |
+95.13% |
| 2001-12-31 | GBX23.77 Million ≈ $2.89K |
-57.27% |
| 2001-03-31 | GBX55.63 Million ≈ $6.77K |
-6.71% |
| 2000-03-31 | GBX59.64 Million ≈ $7.26K |
+283.10% |
| 1999-03-31 | GBX15.57 Million ≈ $1.89K |
+38.85% |
| 1998-03-31 | GBX11.21 Million ≈ $1.36K |
+21.57% |
| 1997-03-31 | GBX9.22 Million ≈ $1.12K |
+6.58% |
| 1996-03-31 | GBX8.65 Million ≈ $1.05K |
-- |
About Genus PLC
Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as techni… Read more